1. Melatonin attenuates intestinal ischemia–reperfusion-induced lung injury in rats by upregulating N-myc downstream-regulated gene 2
   Bo Yang et al, 2015, Journal of Surgical Research CrossRef
2. Determination of melatonin content of different varieties of hemp (Cannabis sativa L.) by liquid chromatography tandem mass spectrometry
   Gianna Allegrone et al, 2019, SN Applied Sciences CrossRef
3. Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways
   Omar A. Ammar et al, 2022, Heliyon CrossRef
4. Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin
   Matthew Hunsaker et al, 2019, Dentistry Journal CrossRef
5. Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic Mimicry in Oral Cancer
   Rui Liu et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
6. Protecting the Melatonin Rhythm through Circadian Healthy Light Exposure
   Maria Bonmati-Carrion et al, 2014, International Journal of Molecular Sciences CrossRef
7. Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models
   Cheng-Yu Yang et al, 2017, Oncotarget CrossRef
8. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
   Wamidh H. Talib et al, 2021, Molecules CrossRef
9. Melatonin Delivery: Transdermal and Transbuccal Evaluation in Different Vehicles
   Ana Flo et al, 2016, Pharmaceutical Research CrossRef
10. Interactions between Environmental Factors and Melatonin Receptor Type 1A Polymorphism in Relation to Oral Cancer Susceptibility and Clinicopathologic Development
    Feng-Yan Lin et al, 2015, PLOS ONE CrossRef
11. Modulation of the tumor microenvironment (TME) by melatonin
    Qi Mu et al, 2021, European Journal of Pharmacology CrossRef
12. Melatonin as a treatment for gastrointestinal cancer: a review
    Zhenlong Xin et al, 2015, Journal of Pineal Research CrossRef
13. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways
    Mohammad Hossein Pourhanifeh et al, 2020, European Journal of Pharmacology CrossRef
14. Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways
    Fawad Ali Shah et al, 2019, Frontiers in Pharmacology CrossRef
15. Mechanisms Underlying Tumor Suppressive Properties of Melatonin
    Stephen C. Bondy et al, 2018, International Journal of Molecular Sciences CrossRef
16. Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action
    Pawel P. Posadzki et al, 2018, BMC Medicine CrossRef
17. Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases
    Po-I Liu et al, 2021, Oncogene CrossRef
18. Melatonin as an oncostatic agent: Review of the modulation of tumor microenvironment and overcoming multidrug resistance
    Niloufar Targhazeh et al, 2022, Biochimie CrossRef
19. Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer
    Mohammad Hossein Asghari et al, 2017, Life Sciences CrossRef
20. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
    null Capote-Moreno et al, 2019, Cancers CrossRef
21. A genome-wide association scan of biological processes involved in oral lichen planus and oral squamous cell carcinoma
    Qiaozhen Yang et al, 2017, Medicine CrossRef
22. Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation
    Po‐Han Lin et al, 2020, Journal of Pineal Research CrossRef